Hi all,
At last the second drug for low platelets - Eltrombopag/Promacta/Revolade has been approved by FDA for patients with Immune Thrombocytopenic Purpura!
http://news.prnewswire.com/ViewConte...4930340&EDATE=
We hope that the trials with treatment with Promacta for low platelets due to treatment of Hepatitis C and cancer like sarcoma will show good effect and that patients with bone marrow diseases can tolerate the drug.
Kind regards
Birgitta-A